Details... ANOTHER BUY...
Opko Health, Inc. (OPK): Gamma Investments Trust Frost , CEO of Opko Health, Inc. purchased 185,000 shares on Aug 21, 2015. The Insider buying transaction was disclosed on Aug 24, 2015 to the Securities and Exchange Commission. The shares were purchased at $12.24 per share for a total value of $2,264,344.50.
Opko Health Inc (NYSE:OPK) witnessed a decline in the market cap on Friday as its shares dropped 3.07% or 0.38 points. After the session commenced at $12.32, the stock reached the higher end at $12.54 while it hit a low of $11.99. With the volume soaring to 14,125,574 shares, the last trade was called at $12. The company has a 52-week high of $19.2. The company has a market cap of $5,563 million and there are 463,617,000 shares in outstanding. The 52-week low of the share price is $8.02.
For the current week, the company shares have a recommendation consensus of Buy. Opko Health Inc (NYSE:OPK) has lost 7.69% during the past week and dropped 28.91% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 2.04%. Opko Health Inc (NYSE:OPK) has underperformed the index by 24.99% in the last 4 weeks. Investors should watch out for further signals and trade with caution.
The company shares have rallied 35.14% in the past 52 Weeks. On June 3, 2015 The shares registered one year high of $19.2 and one year low was seen on October 13, 2014 at $8.02. The 50-day moving average is $15.38 and the 200 day moving average is recorded at $15.15. S&P 500 has rallied 1.35% during the last 52-weeks. Opko Health, Inc. has dropped 32.51% during the last 3-month period . Year-to-Date the stock performance stands at 20.12%.
On a different note, The Company has disclosed insider buying and selling activities to the Securities Exchange, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the CEO of Opko Health, Inc., Frost Gamma Investments Trust, had purchased 7,200 shares in a transaction dated on July 8, 2015. The transaction was executed at $16.55 per share with total amount equaling $119,160. Opko Health Inc (NYSE:OPK): According to 3 Analysts, The short term target price has been estimated at $ 16.67.The target price could deviate by a maximum of $5.77 from the forecast price. In the near term, the target price could hit a high of $20 and a low of $ 10.
OPKO Health, Inc. (OPKO) is a multi-national biopharmaceutical and diagnostics company. OPKO is developing a range of solutions to diagnose, treat and prevent various conditions, including molecular diagnostics tests, laboratory developed tests (LTDs), point-of-care tests and pharmaceuticals and vaccines. The Company operates in two segments: pharmaceutical and diagnostics. The pharmaceutical segment consists of two operating segments: pharmaceutical research and development segment which is focused on the research and development of pharmaceutical products and vaccines, and the pharmaceutical operations it acquired in Chile, Mexico, Israel, and Spain through acquisitions in those countries. Effective May 28, 2014, OPKO Health Inc acquired Inspiro Medical Ltd, a Misgav-based manufacturer and wholesaler of pharmaceuticals.
Tweet
Pin It
About The Author
Justin Cunninghan
You can contact the author at Justin.Cunninghan@insidertradingreport.org
